Decoy Therapeutics, Inc. (DCOY)
3.03
-0.03
(-0.98%)
USD |
NASDAQ |
Sep 02, 16:00
2.88
-0.15
(-4.95%)
After-Hours: 20:00
Decoy Therapeutics Cash from Operations (Annual) : -4.827M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -4.827M |
| December 31, 2024 | -4.525M |
| December 31, 2023 | -12.85M |
| December 31, 2022 | -17.60M |
| December 31, 2021 | -10.20M |
| December 31, 2020 | -10.31M |
| Date | Value |
|---|---|
| December 31, 2019 | -11.58M |
| December 31, 2018 | 4.177M |
| December 31, 2017 | -27.72M |
| December 31, 2016 | -32.05M |
| December 31, 2015 | -20.75M |
| December 31, 2014 | -6.929M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Palatin Technologies, Inc. | -21.31M |
| Unicycive Therapeutics, Inc. | -31.32M |
| Nuvectis Pharma, Inc. | -16.01M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |